Breast cancer treatment and its impact on survival in Morocco: a study over a decade.

Background: In Morocco, much progress has been made in breast cancer treatment. However, there is limited information on survival outcomes of breast cancer patients according to their therapeutic management.

Methods: A pattern-of-care study was conducted in Morocco's two main oncology centres: Rabat and Casablanca and has shown that major progress has been made in the quality of care with survival rates comparable to those in developed countries.

Occult primary breast cancer: Two cases report and literature review.

Introduction And Importance: Occult breast cancer (OBC) is defined as a clinically recognizable metastatic carcinoma arising from an undetectable primary breast tumor.

Presentation Of Case: We report in this work 2 cases of occult breast cancer treated at the Mohammed VI center of onco-gynecology of the CHU of Casablanca.

Clinical Discussion: Significant advances in breast imaging have occurred since its description, decreasing its incidence.

[Toxic habits and diet behaviors of patients with breast cancer treated in the Mohammed VI Cancer Treatment Center, Casablanca].

Introduction: Breast cancer is a major public health challenge. The purpose of this study is to describe the sociodemographic profile, toxic habits and diet profile of patients suffering from breast cancer treated in the Mohammed VI Cancer Treatment Center, in Casablanca.

Methods: We conducted a cross-sectional study of 305 female patients newly diagnosed with breast cancer.

Cancer management challenge in a developing country in COVID-19 pandemic: reflection of a group of Moroccan oncologists.

Management of cancer patients during the COVID-19 pandemic is a worldwide challenge - in particular in developing countries where the risk of saturation of health facilities and intensive care beds must be minimized. The first case of COVID-19 was declared in Morocco on 2 March 2020, after which a panel of Moroccan experts, consisting of medical oncologists from universities and regional and private oncology centers, was promptly assembled to conduct a group reflection on cancer patient's management. The main objective is to protect the immunocompromised population from the risk of COVID-19, while maintaining an adequate management of cancer, which can quickly compromise their prognosis.

[A case-control study on dietary risk factors for colorectal cancer in Morocco].

Introduction: given its frequency and severity, colorectal cancer is a major public health problem. Diet plays a key role in preventing this type of cancer. The purpose of our study was to determine dietary risk factors for colorectal cancer in our Moroccan context.

[Small cell neuroendocrine carcinoma of the bladder: Report of five cases and a review of the literature].

Neuroendocrine small cell carcinoma of the bladder is a rare and aggressive tumour, accounting for less than 1% of all bladder tumours. Given its rarity and the absence of randomized trials, the therapeutic management of these tumours remains difficult. By analogy with small cell lung cancer, multimodal treatment is often proposed.

Lung adenocarcinoma with thyroid metastasis: a case report.

Background: The metastases of a primary lung cancer over the thyroid gland are extremely rare. We report on an unusual presentation of thyroid metastasis of lung cancer in order to improve the management of similar cases.

Case Presentation: Three years ago, a Moroccan male 59-year-old was admitted for dyspnea, dry cough, and chest pain.

[Primary intramuscular non-Hodgkin's lymphoma in young subjects: about a case and review of the literature].

Primary extra-ganglionic non-Hodgkin's lymphoma (NHL) is rare and its primary intramuscular location is exceptional, as it account for less than 0.5% of all patients. It generally affects men, with an average age of 70 years.

[Synchronous bilateral breast cancer: experiences in the Mohammed VI Cancer Treatment Center, CHU Ibn Rochd, Casablanca].

Synchronous bilateral breast cancers (SBBC) are characterized by extensive clinical and morphological heterogeneity, with an frequency between 1.5 and 3.2%.

[Breast cancer in Morocco: phenotypic profile of tumors].

Breast cancer is most common in women and it is among the leading causes of cancer related deaths. The curability of this type of tumor is increasing thanks to screening programs and treatment advances which have certainly enhanced patient survival. But challenges remain, particularly in respect of phenotypic instability of cancer cells.

[Mucinous carcinoma of the breast: Clinical, biological and evolutive profile].

Purpose: Mucinous carcinoma of the breast accounts for 1 to 4% of all breast cancer. There are two histological subtypes: mixed mucinous carcinoma, where the ductal carcinoma is associated with the colloid component, and pure mucinous carcinoma, with a favorable prognosis, where the mucus surrounds the tumour tissue and constitutes a mechanical barrier limiting cell invasion and making this form less aggressive. Our study aimed to determine retrospectively the main epidemiological, clinical, biological, and therapeutic features, as well as the prognosis of this rare form of breast carcinoma.

[Therapeutic outcomes of medulloblastoma in Casablanca from 2000 to 2012].

Purpose: To describe the therapeutic results, with the aim to contribute to improving the care of patients with medulloblastoma.

Patients And Methods: A retrospective study of 69 cases of medulloblastoma collected in the university hospital Ibn Rochd of Casablanca between 2000 and 2012.

Results: Fifty-three children with an average age of 9 years and 16 adults with an average age of 32.

Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report.

Introduction: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability of chemotherapy or targeted therapy, and to a lack of financial resources or surgeons' lack of knowledge of other therapeutic options.